Schmitz Christoph, Alt Christopher, Wuerfel Tobias, Milz Stefan, Dinzey Jacqueline, Hill Ashley, Sikes Katie J, Burton Lindsey H, Easley Jeremiah, Stewart Holly L, Puttlitz Christian M, Gadomski Benjamin C, Labus Kevin M, Pearce David A, Maffulli Nicola, Alt Eckhard U
Institute of Anatomy, Faculty of Medicine, LMU Munich, 80331 Munich, Germany.
IsarKlinikum, 80331 Munich, Germany.
Int J Mol Sci. 2025 Jul 16;26(14):6800. doi: 10.3390/ijms26146800.
Current treatment strategies for partial tendon tears often lack the capacity to promote true tissue regeneration and improve long-term clinical outcomes. This study tested the hypothesis that treatment of a partial defect in the rabbit common calcaneus tendon (CCT) with uncultured, unmodified, autologous, adipose-derived regenerative cells (UA-ADRCs) enables regenerative healing without scar formation. A full-thickness, 3 mm defect was produced in the midsubstance of the right gastrocnemius tendon, a component of the CCT, in adult female New Zealand white rabbits. Animals received either an injection of 28.3 × 10 UA-ADRCs in 0.5 mL Ringer's lactated solution (RLS) or saline, or RLS or saline alone as sham treatment. Tendons were analyzed 4 or 12 weeks post-treatment using histology, immunohistochemistry and non-destructive biomechanical testing. UA-ADRC-treated tendons showed newly formed connective tissue consistent with tendon regeneration, whereas sham-treated tendons developed scar tissue. Biomechanical testing showed significantly higher percent relaxation in UA-ADRC-treated tendons compared to sham controls ( < 0.05), indicating greater viscoelasticity characteristic of healthy or well-integrated tissue. Together, these findings suggest that UA-ADRC therapy may provide a regenerative, structure-modifying treatment for partial tendon tears.
目前针对部分肌腱撕裂的治疗策略往往缺乏促进真正组织再生和改善长期临床结果的能力。本研究检验了以下假设:用未培养、未修饰的自体脂肪来源再生细胞(UA-ADRCs)治疗兔跟腱(CCT)的部分缺损能够实现无瘢痕形成的再生愈合。在成年雌性新西兰白兔的右腓肠肌腱(CCT的一个组成部分)中部制造一个3毫米的全层缺损。动物接受在0.5毫升乳酸林格氏液(RLS)中注射28.3×10的UA-ADRCs或生理盐水,或单独注射RLS或生理盐水作为假治疗。在治疗后4周或12周,使用组织学、免疫组织化学和非破坏性生物力学测试对肌腱进行分析。接受UA-ADRC治疗的肌腱显示出与肌腱再生一致的新形成的结缔组织,而接受假治疗的肌腱形成了瘢痕组织。生物力学测试显示,与假对照组相比,接受UA-ADRC治疗的肌腱的松弛百分比显著更高(<0.05),表明健康或良好整合组织具有更大的粘弹性特征。总之,这些发现表明UA-ADRC疗法可能为部分肌腱撕裂提供一种再生性的、结构改良的治疗方法。